alpha-methylornithine has been researched along with Carcinoma, Ehrlich Tumor in 3 studies
alpha-methylornithine: inhibitor of ornithine decarboxylase; RN given refers to cpd without isomeric designation
Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oredsson, S | 2 |
| Anehus, S | 2 |
| Heby, O | 3 |
| Linden, M | 1 |
| Persson, L | 1 |
| Oredsson, SM | 1 |
3 other studies available for alpha-methylornithine and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Irreversible inhibition of the early increase in ornithine decarboxylase activity following growth stimulation is required to block Ehrlich ascites tumor cell proliferation in culture.
Topics: Animals; Carboxy-Lyases; Carcinoma, Ehrlich Tumor; Cell Division; Eflornithine; Kinetics; Mice; Orni | 1980 |
Cytocidal effect of alpha-methylornithine, a competitive inhibitor of ornithine decarboxylase, on ehrlich ascites tumor cells in vivo.
Topics: Animals; Antineoplastic Agents; Carboxy-Lyases; Carcinoma, Ehrlich Tumor; Cell Cycle; Male; Mice; Or | 1980 |
Ornithine decarboxylase inhibitors increase the cellular content of the enzyme: implications for translational regulation.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Line; Cycloheximide; DNA; Eflornithine; Half-Life; Nucleic A | 1985 |